Silva Pharmaceuticals Limited (DSE:SILVAPHL)

Bangladesh flag Bangladesh · Delayed Price · Currency is BDT
10.10
+0.10 (1.00%)
At close: Feb 26, 2026
-17.89%
Market Cap 1.38B
Revenue (ttm) 356.99M
Net Income (ttm) -145.41M
Shares Out 136.50M
EPS (ttm) -1.07
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 413,403
Average Volume 285,696
Open 10.00
Previous Close 10.00
Day's Range 10.00 - 10.20
52-Week Range 7.60 - 14.40
Beta -0.04
RSI 58.10
Earnings Date Apr 28, 2026

About Silva Pharmaceuticals

Silva Pharmaceuticals Limited engages in manufacturing and marketing of pharmaceuticals finished products in Bangladesh and internationally. The company offers drugs for various categories, including antibiotics, analgesics, anti-diabetics, narcotics, anti-pyretics, anti-inflammatory, anti ulcerants, antiemetic, gastroprokinetic, antihistamine, anti-spasmodic expectorants, and vitamins and mineral. It also provides pharmaceutical products in therapeutic areas, such as anemias and other blood disorders, central nervous system, gastro- intestinal... [Read more]

Industry Pharmaceutical Preparations
Founded 2001
Employees 624
Stock Exchange Dhaka Stock Exchange
Ticker Symbol SILVAPHL
Full Company Profile

Financial Performance

In fiscal year 2025, Silva Pharmaceuticals's revenue was 383.65 million, a decrease of -36.02% compared to the previous year's 599.66 million. Losses were -132.95 million, 106.2% more than in 2024.

Financial Statements

News

There is no news available yet.